<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04731753</url>
  </required_header>
  <id_info>
    <org_study_id>BSN-C2533</org_study_id>
    <nct_id>NCT04731753</nct_id>
  </id_info>
  <brief_title>PMCF Study to Examine the Debridement Pad Cutimed DebriClean</brief_title>
  <official_title>Post Market Clinical Follow up Study to Examine Clinical Performance of the Debridement Pad Cutimed DebriClean</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BSN Medical GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BSN Medical GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Documentation of the performance and safety of the debridement pad Cutimed DebriClean in&#xD;
      daily clinical practice&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      60 subjects with superficial wounds in need of debridement will undergo mechanical&#xD;
      debridement with the study product.&#xD;
&#xD;
      Per subject, one application of the study product will be documented including photo&#xD;
      documentation of the wound and evaluation of the wound bed condition and wound size before&#xD;
      and after the debridement.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 27, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of wound bed condition from baseline to assessment immediately after the mechanical debridement (within one study visit)</measure>
    <time_frame>assessed immediately before and immediately after the mechanical debridement (within one study visit)</time_frame>
    <description>Percentage of wound coverage with debris/necrosis/slough Wound edge cleaned smooth Surrounding skin cleaned e.g. from skin flakes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound size after and before wound debridement</measure>
    <time_frame>assessed immediately before and immediately after the mechanical debridement (within one study visit)</time_frame>
    <description>Wound length and wound width are measured using a wound ruler. Wound size is calculated using the formula A = length x width x π/4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time needed for the debridement procedure</measure>
    <time_frame>Time is measured during the debridement procedure</time_frame>
    <description>Time from start to completion of the debridement procedure in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Debris/necrosis/slough absorbed by test product</measure>
    <time_frame>assessed immediately after the mechanical debridement</time_frame>
    <description>assessed by the investigator (five categories)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Structural integrity of the test product</measure>
    <time_frame>assessed immediately after the mechanical debridement</time_frame>
    <description>assessed by the investigator (e.g. change in shape, loosening of fibers, …)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain during the debridement procedure</measure>
    <time_frame>assessed immediately after the debridement procedure</time_frame>
    <description>Patient reported pain assessed using a visual analogue scale. If applicable, duration of pain is documented.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse device effects</measure>
    <time_frame>assessed immediately after the debridement procedure</time_frame>
    <description>Discomfort, pressure, burning sensation, bleeding, and irritation of the periwound skin during or after the mechanical debridement, other adverse device effects swelling; redness</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Wound</condition>
  <arm_group>
    <arm_group_label>Group treated with study product</arm_group_label>
    <description>Subjects will undergo one mechanical debridement procedure with Cutimed DebriClean</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>mechanical debridement</intervention_name>
    <description>The mechanical debridement is performed using the debridement pad Cutimed DebriClean. After the pad is moistened with wound-cleansing solution, the wound is cleaned using circular movements while applying gentle pressure.</description>
    <arm_group_label>Group treated with study product</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with superficial wounds in need of debridement, for example diabetic ulcers,&#xD;
        venous and arterial ulcers, pressure sores, postoperative wounds and wounds healing by&#xD;
        secondary intention, superficial burns, the absorption of exudate, slough and dry skin&#xD;
        flakes.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female subjects aged 18 years or older with full legal competence&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
          -  Subjects with wounds in need of debridement, especially diabetic ulcers, venous and&#xD;
             arterial ulcers, pressure sores, postoperative wounds and wounds healing by secondary&#xD;
             intention, superficial burns&#xD;
&#xD;
          -  Superficial wound&#xD;
&#xD;
          -  Minimum 30 % of the wound is covered by debris, necrosis or slough&#xD;
&#xD;
          -  Wound size &gt; 4 cm²&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects not willing to participate or to attend the scheduled study visit&#xD;
&#xD;
          -  Known sensitivity or allergy to the product components&#xD;
&#xD;
          -  Severe pain or hyperaesthesia in the wound area&#xD;
&#xD;
          -  Patients who are pregnant or lactating&#xD;
&#xD;
          -  Drug abuse or alcohol abuse&#xD;
&#xD;
          -  Patients who participate in any other clinical study investigating drugs or medical&#xD;
             devices&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leanne Atkin, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Huddersfield</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Swaantje Hoffstedt</last_name>
    <phone>+49 174 - 3162215</phone>
    <email>swaantje.hoffstedt@essity.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sandra Tobisch</last_name>
    <phone>+49 40 - 59361 2299</phone>
    <email>sandra.tobisch@essity.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Praxis am Stadtpark</name>
      <address>
        <city>Ahlen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>59227</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Rahmati, Dr. med.</last_name>
      <phone>+49 177 4048222</phone>
      <email>christian.rahmati@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitäres Herz- und Gefäßzentrum, Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20251</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eike Sebastian Debus, Prof. Dr.</last_name>
      <phone>+49 40 741053178</phone>
      <email>h.hidalgo@uke.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pinderfields Hospital</name>
      <address>
        <city>Wakefield</city>
        <state>West Yorkshire</state>
        <zip>WF1 3DG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 18, 2021</study_first_submitted>
  <study_first_submitted_qc>January 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 1, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Debridement</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No IPD will be shared. Data are needed for post market clinical follow up.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

